Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Sweat hypersensitivity can cause severe skin issues in horses.

A woman with severe angioedema improved significantly after treatment with rituximab.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Stem-cell therapy shows promise for skin conditions but needs more research.

The woman's hair loss is likely stress-related and should improve without treatment.

The document concludes that scalp conditions have various causes and can present in many different ways.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Exosomes show promise for future tissue regeneration.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Activin A increases inner ear hair cell development, while follistatin decreases it.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Topical drugs and near-infrared light therapy show potential for treating alopecia.